Q29056 AF NFT

Interleukin-1 receptor antagonist protein

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicym6r5b437lclzbibdpqev7kg7h6kvi6fxn6rzvmhhlozllcnt3q/metadata.json
IPFS of structure file: 
bafybeicnhebnxjhzx7b5weyo4nwscmesliswyoqesokyxduhq4sfkp52ya/AF-Q29056-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7d626243aF5Ca6d5eB0779378463DcADA09F69c7
First NFT owner address (bech32): 
genesis1043xysa0tjndt6c80ymcgc7u4ksf76w8uevgec
Current NFT ID #187817 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
187817
Accession (UniProt):
Q29056
Name::
Interleukin-1 receptor antagonist protein
Experimental Method:
Predicted structure
Sequence source:
SUS SCROFA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q29056 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q29056|IL1RA_PIG Interleukin-1 receptor antagonist protein OS=Sus scrofa OX=9823 GN=IL1RN PE=2 SV=1 MEVSRYLCSYLISFLLFLFHSETACHPLGKRPCRMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNTKLEEKIDVVPVEPHFVFLGIHGGKLCLSCVKSGDEMKLQLDAVNITDLRKNSEQDKRFTFIRSDSGPTTSFESAACPGWFLCTALEADQPVGLTNTPKAAVKVTKFYFQQDQ